LANTHEUS HOLDINGS INC (LNTH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LNTH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LNTH | LeadIndependentDirector; Chair | 61 | ["Strong commercial and operational management background", "Extensive experience in the pharmaceutical industry", "Former Chief Operating Officer, Endo Health Solutions, Inc.", "Former CEO, Nora Therapeutics, Inc.", "Former Company Group Chairperson for the Worldwide Virology business unit of Johnson & Johnson", "Former President, Centocor, Inc.", "Led marketing communications for gastrointestinal drug Prilosec\u00ae at Astra-Merck Inc."] | ["Chair", "Nominating and Corporate Governance Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IRWD | Chair | 61 | ["Former Chief Operating Officer, Endo Health Solutions, Inc.","CEO of Nora Therapeutics, Inc.","Company group chair for the worldwide virology business unit of Johnson & Johnson","President of Centocor, Inc.","Oversaw development and launches of several products, including Remicade®","Led marketing communications for gastrointestinal drug Prilosec® at Astra-Merck Inc.","Board member of Lantheus Holdings, Inc. and Xellia Pharmaceuticals ApS","Served on multiple boards including Aerie Pharmaceuticals, Inc., Trevena, Inc."] | ["Audit Committee","Governance and Nominating Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Director since 2017 Independent 61 years old Committees: Nominating and Corporate Governance Committee (Chair) Specific Expertise: Ms. McHugh was chosen as our Lead Independent Director because of her strong commercial and operational management background and extensive experience in the pharmaceutical industry. Career Highlights: Former Chief Operating Officer, Endo Health Solutions, Inc., where Ms. McHugh was responsible for the specialty pharmaceutical and generic drug businesses Former CEO, Nora Therapeutics, Inc., a venture capital backed biotech startup company focused on developing novel therapies for the treatment of infertility disorders Former Company Group Chairperson for the Worldwide Virology business unit of Johnson & Johnson Former President, Centocor, Inc., a Johnson & Johnson subsidiary, where Ms. McHugh oversaw the development and launches of several products, including Remicade (infliximab) Led marketing communications for gastrointestinal drug Prilosec (omeprazole) at Astra-Merck Inc. Other Public Company Boards: Current Chairperson of the Board of Directors and a member of the Nominating and Governance Committee and Audit Committee, Ironwood Pharmaceuticals, Inc. Other Boards and Awards: Current Director, New Xellia Group A/S Senior Advisory Board, HealthCare Royalty Partners Prior Director, Evelo Biosciences Inc. Director, Aerie Pharmaceuticals Inc. Director, Trevena Pharmaceuticals Director, EPIRUS Pharmaceuticals, Inc. Director, ViroPharma Inc Director, Biotechnology Industry Organization Director, New England Healthcare Institute Director, Pennsylvania Biotechnology Association Education: B.S., Pennsylvania State University MBA, St. Joseph s University